CHONDRONEST SA has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in EPO (European Patent Office), United States and Brazil. Its main competitors in its focus markets medical technology, organic fine chemistry and macromolecular chemistry and polymers are SHANDONG MANTAK BIOMEDICAL ENG CO LTD, KZ VNII SINT KAUCHUKA IM AKADE and MEDGRAFT MICROTECH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 2 | |
#2 | United States | 2 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | Hungary | 1 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Singapore | 1 | |
#9 | Taiwan | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Organic fine chemistry | |
#3 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Object sterilising | |
#2 | Heterocyclic compounds | |
#3 | Macromolecular compounds compositions |
# | Name | Total Patents |
---|---|---|
#1 | Schwitzguébel Thierry | 7 |
#2 | Schwitzguebel Thierry | 4 |
#3 | Thierry Schwitzguébel | 1 |
#4 | Thierry Schwitzguebel | 1 |
Publication | Filing date | Title |
---|---|---|
US2020017518A1 | Bis-Cyclic Carbonate Molecule with Bis(1,3)-Dioxin-Dione Structure | |
HUE044268T2 | Composition containing glycosaminoglycans and proteins |